Gilead Sciences, Inc. <GILD.O>: Barclays Cuts Target Price to $145 From $155
GILD•Related News
Verisk acquires McKenzie Intelligence Services
VRSK•
Generac tops quarterly profit estimates on strong data center-driven generator demand
GNRC•
Canada's CGI Q3 revenue slightly beats estimates
GIB•
Xylem Inc <XYL.N>: Mizuho raises target price to $130 from $124
XYL•
Maven exits McKenzie Intelligence Solutions in sale to Verisk
VRSK•